Skip to main content

Advertisement

Log in

Photodynamic therapy in oral cancer: a review of clinical studies

  • Review Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

A significant mortality rate is associated with oral cancer, particularly in cases of late-stage diagnosis. Since the last decades, oral cancer survival rates have only gradually improved despite advances in treatment. This poor success rate is mainly due to the development of secondary tumors, local recurrence, and regional failure. Invasive treatments frequently have a negative impact on the aesthetic and functional outcomes of survivors. Novel approaches are thus needed to manage this deadly disease in light of these statistics. In photodynamic therapy (PDT), a light-sensitive medication called a photosensitizer is given first, followed by exposure to light of the proper wavelength that matches the absorbance band of the photosensitizer. The tissue oxygen-induced cytotoxic free radicals kill tumor cells directly, harm the microvascular structure, and cause inflammatory reactions at the targeted sites. In the case of early lesions, PDT can be used as a stand-alone therapy, and in the case of advanced lesions, it can be used as adjuvant therapy. The current review article discussed the uses of PDT in oral cancer therapy based on recent advances in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

    Article  CAS  PubMed  Google Scholar 

  2. Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91(1):13–23.

    Article  PubMed  Google Scholar 

  3. Leemans CR, Snijders PJ, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269.

    Article  CAS  PubMed  Google Scholar 

  4. Scully C, Porter S. Oral cancer. West J Med. 2001;174(5):348–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hwang E, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M. Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007. Oral Oncol. 2013;49(11):1072–6.

    Article  PubMed  Google Scholar 

  6. Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N, Foster C, Wickramasinghe K. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob Health. 2017;5(3):e277–89.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mummudi N, Agarwal J, Chatterjee S, Mallick I, Ghosh-Laskar S. Oral cavity cancer in the Indian subcontinent–challenges and opportunities. Clin Oncol. 2019;31(8):520–8.

    Article  CAS  Google Scholar 

  8. Hsu W-L, Yu KJ, Chiang C-J, Chen T-C, Wang C-P. Head and neck cancer incidence trends in Taiwan, 1980–2014. Int J Head Neck Sci. 2017;1(3):180–9.

    Google Scholar 

  9. Westra WH, Lewis JS. Update from the 4th edition of the world health organization classification of head and neck tumours: oropharynx. Head Neck Pathol. 2017;11(1):41–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. VanderWalde NA, Fleming M, Weiss J, Chera BS. Treatment of older patients with head and neck cancer: a review. Oncologist. 2013;18(5):568–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Santoni A, Santoni M, Arcuri E. Chronic cancer pain: opioids within tumor microenvironment affect neuroinflammation, tumor and pain evolution. Cancers (Basel). 2022;14(9):2253.

    Article  CAS  PubMed  Google Scholar 

  12. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Huber MA, Tantiwongkosi B. Oral and oropharyngeal cancer. Med Clin North Am. 2014;98(6):1299–321.

    Article  PubMed  Google Scholar 

  14. Rokaya D. Role of maxillofacial prosthetics in the head-and-neck cancer rehabilitation. Saint’s Int Dental J. 2021;5(2):35–35.

    Article  Google Scholar 

  15. Amornvit P, Rokaya D, Shrestha B, Srithavaj T. Prosthetic rehabilitation of an ocular defect with post-enucleation socket syndrome: a case report. Saudi Dent J. 2014;26(1):29–32.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Humagain M, Rokaya D. Integrating digital technologies in dentistry to enhance the clinical success. Kathmandu Univ Med J (KUMJ). 2019;17(68):256–7.

    PubMed  Google Scholar 

  17. Alqurashi H, Khurshid Z, Syed AUY, Rashid Habib S, Rokaya D, Zafar MS. Polyetherketoneketone (PEKK): an emerging biomaterial for oral implants and dental prostheses. J Adv Res. 2021;28:87–95.

    Article  CAS  PubMed  Google Scholar 

  18. Kolokythas A. Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I. J Oral Maxillofac Res. 2010;1(3):e1.

    PubMed  PubMed Central  Google Scholar 

  19. Rigual N, Shafirstein G, Cooper MT, Baumann H, Bellnier DA, Sunar U, Tracy EC, Rohrbach DJ, Wilding G, Tan W, Sullivan M, Merzianu M, Henderson BW. Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res. 2013;19(23):6605–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rigual NR, Thankappan K, Cooper M, Sullivan MA, Dougherty T, Popat SR, Loree TR, Biel MA, Henderson B. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg. 2009;135(8):784–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34(1):39–43.

    Article  CAS  PubMed  Google Scholar 

  22. Epstein JB, Thariat J, Bensadoun R-J, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy. CA: Cancer J Clin. 2012;62(6):400–22.

    PubMed  Google Scholar 

  23. Raber-Durlacher JE, Barasch A, Peterson DE, Lalla RV, Schubert MM, Fibbe WE. Oral complications and management considerations in patients treated with high-dose chemotherapy. Support Cancer Ther. 2004;1(4):219–29.

    Article  PubMed  Google Scholar 

  24. Dreizen S, Daly TE, Drane JB, Brown LR. Oral complications of cancer radiotherapy. Postgrad Med. 1977;61(2):85–92.

    Article  CAS  PubMed  Google Scholar 

  25. Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. The patient’s perspective. Cancer Nurs. 2002;25(6):461–7.

    Article  PubMed  Google Scholar 

  26. Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918–31.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nauta JM, van Leengoed HL, Star WM, Roodenburg JL, Witjes MJ, Vermey A. Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications. Eur J Oral Sci. 1996;104:69–81.

    Article  CAS  PubMed  Google Scholar 

  28. Saini R, Lee NV, Liu KY, Poh CF. Prospects in the application of photodynamic therapy in oral cancer and premalignant lesions. Cancers (Basel). 2016;8(9):83.

    Article  PubMed  Google Scholar 

  29. Al-Sharif RM, Batwa DY, Alotaibi TN, Alwadai NM, Alsharif AH, Azhar NA, Moulana AA, Alahmadi SM, Althobaiti MY, Bayyumi DF, Alzahrani WI. Epidemiology and types of oral cancer. Int J Commut Med Public Health. 2022;9(2):6.

    Google Scholar 

  30. Banakar M, Ardekani ST, Zare R, Malekzadeh M, Mirhadi H, Khademi B, Rokaya D. Oral squamous cell carcinoma: the role of BIRC6 serum level. Biomed Res Int. 2022;2022:5425478.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Nyst HJ, Tan IB, Stewart FA, Balm AJ. Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? Photodiagn Photodyn Ther. 2009;6(1):3–11.

    Article  CAS  Google Scholar 

  32. Allison RR, Bagnato VS, Sibata CH. Future of oncologic photodynamic therapy. Future Oncol. 2010;6(6):929–40.

    Article  CAS  PubMed  Google Scholar 

  33. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380–7.

    Article  CAS  PubMed  Google Scholar 

  34. Robertson CA, Evans DH, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B Biol. 2009;96(1):1–8.

    Article  CAS  Google Scholar 

  35. Raghavendra M, Koregol A, Bhola S. Photodynamic therapy: a targeted therapy in periodontics. Aust Dent J. 2009;54(Suppl 1):S102–9.

    Article  PubMed  Google Scholar 

  36. Shafirstein G, Friedman A, Siegel E, Moreno M, Bäumler W, Fan CY, Morehead K, Vural E, Stack BC Jr, Suen JY. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia. Arch Otolaryngol Head Neck Surg. 2011;137(11):1117–23.

    Article  PubMed  Google Scholar 

  37. Harada Y, Murayama Y, Takamatsu T, Otsuji E, Tanaka H. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence imaging for tumor detection: recent advances and challenges. Int J Mol Sci. 2022;23(12):6478.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Romeo U, Russo N, Palaia G, Tenore G, Del Vecchio A. Oral proliferative verrucous leukoplakia treated with the photodynamic therapy: a case report. Ann Stomatol. 2014;5(2):77–80.

    Google Scholar 

  39. Soukos NS, Goodson JM. Photodynamic therapy in the control of oral biofilms. Periodontology. 2011;55(1):143–66.

    Article  Google Scholar 

  40. Mostafa D, Tarakji B. Photodynamic therapy in treatment of oral lichen planus. J Clin Med Res. 2015;7(6):393–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Choi SH, Kim KH, Song KH. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial. Br J Dermatol. 2015;173(1):184–91.

    Article  CAS  PubMed  Google Scholar 

  42. Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM. Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Lasers Surg Med. 2006;38(1):33–8.

    Article  PubMed  Google Scholar 

  43. Takasaki AA, Aoki A, Mizutani K, Schwarz F, Sculean A, Wang CY, Koshy G, Romanos G, Ishikawa I, Izumi Y. Application of antimicrobial photodynamic therapy in periodontal and peri-implant diseases. Periodontology. 2009;2000(51):109–40.

    Article  Google Scholar 

  44. Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Fateh M, Djavid GE. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: a case report. Med Oral, Patol Oral y Cirugia Bucal. 2006;11(2):E126–9.

    Google Scholar 

  45. Sadaksharam J, Nayaki KP, Selvam NP. Treatment of oral lichen planus with methylene blue mediated photodynamic therapy–a clinical study. Photodermatol Photoimmunol Photomed. 2012;28(2):97–101.

    Article  CAS  PubMed  Google Scholar 

  46. Pavlic V, Vujic-Aleksic V. Phototherapy approaches in treatment of oral lichen planus. Photodermatol Photoimmunol Photomed. 2014;30(1):15–24.

    Article  PubMed  Google Scholar 

  47. Sobaniec S, Bernaczyk P, Pietruski J, Cholewa M, Skurska A, Dolińska E, Duraj E, Tokajuk G, Paniczko A, Olszewska E, Pietruska M. Clinical assessment of the efficacy of photodynamic therapy in the treatment of oral lichen planus. Lasers Med Sci. 2013;28(1):311–6.

    Article  PubMed  Google Scholar 

  48. Ali-Seyed M, Bhuvaneswari R, Soo KC, Olivo M. Photolon™—photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Int J Oncol. 2011;39(4):821–31.

    CAS  PubMed  Google Scholar 

  49. Andreadis D, Pavlou A-M, Sotiriou E, Vrani F, Ioannides D, Kolokotronis A. Utility of photodynamic therapy for the management of oral potentially malignant disorders and oral cancer. Transl Res Oral Oncol. 2016. https://doi.org/10.1177/2057178X16669161.

    Article  Google Scholar 

  50. Jajarm HH, Falaki F, Sanatkhani M, Ahmadzadeh M, Ahrari F, Shafaee H. A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial. Lasers Med Sci. 2015;30(5):1475–80.

    Article  PubMed  Google Scholar 

  51. Zanin IC, Lobo MM, Rodrigues LK, Pimenta LA, Höfling JF, Gonçalves RB. Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci. 2006;114(1):64–9.

    Article  CAS  PubMed  Google Scholar 

  52. Usacheva MN, Teichert MC, Biel MA. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med. 2001;29(2):165–73.

    Article  CAS  PubMed  Google Scholar 

  53. Kim MM, Darafsheh A. Light sources and dosimetry techniques for photodynamic therapy. Photochem Photobiol. 2020;96(2):280–94.

    Article  CAS  PubMed  Google Scholar 

  54. Mang TS. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1(1):43–8.

    Article  Google Scholar 

  55. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002;17(3):173–86.

    Article  CAS  PubMed  Google Scholar 

  56. Wilson BC. Photodynamic therapy: light delivery and dosage for second-generation photosensitizers. Ciba Found Symp. 1989;146:60–73.

    CAS  PubMed  Google Scholar 

  57. Saleh BEA, Teich MC. Fundamentals of photonics. Hoboken: Wiley; 2019.

    Google Scholar 

  58. Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, Chiang CP. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med. 2005;37(2):114–22.

    Article  PubMed  Google Scholar 

  59. Tsai JC, Chiang CP, Chen HM, Huang SB, Wang CW, Lee MI, Hsu YC, Chen CT, Tsai T. Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med. 2004;34(1):18–24.

    Article  PubMed  Google Scholar 

  60. Yu CH, Lin HP, Chen HM, Yang H, Wang YP, Chiang CP. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light. Lasers Surg Med. 2009;41(9):628–33.

    Article  PubMed  Google Scholar 

  61. Hempstead J, Jones DP, Ziouche A, Cramer GM, Rizvi I, Arnason S, Hasan T, Celli JP. Low-cost photodynamic therapy devices for global health settings: characterization of battery-powered LED performance and smartphone imaging in 3D tumor models. Sci Rep. 2015;5:10093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Chen J, Keltner L, Christophersen J, Zheng F, Krouse M, Singhal A, Wang SS. New technology for deep light distribution in tissue for phototherapy. Cancer J (Sudbury, Mass). 2002;8(2):154–63.

    Article  Google Scholar 

  63. Schmidt MH, Bajic DM, Reichert KW 2nd, Martin TS, Meyer GA, Whelan HT. Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery. 1996;38(3):552–6.

    CAS  PubMed  Google Scholar 

  64. Burch S, London C, Seguin B, Rodriguez C, Wilson BC, Bisland SK. Treatment of canine osseous tumors with photodynamic therapy: a pilot study. Clin Orthop Relat Res. 2009;467(4):1028–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Wilson BC, Patterson MS. The physics of photodynamic therapy. Phys Med Biol. 1986;31(4):327–60.

    Article  CAS  PubMed  Google Scholar 

  66. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–66.

    Article  CAS  PubMed  Google Scholar 

  67. Vohra F, Al-Kheraif AA, Qadri T, Hassan MI, Ahmed A, Warnakulasuriya S, Javed F. Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review. Photodiagn Photodyn Ther. 2015;12(1):150–9.

    Article  Google Scholar 

  68. Cerrati EW, Nguyen SA, Farrar JD, Lentsch EJ. The efficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis. Ear Nose Throat J. 2015;94(2):72–9.

    Article  PubMed  Google Scholar 

  69. Bredell MG, Besic E, Maake C, Walt H. The application and challenges of clinical PD-PDT in the head and neck region: a short review. J Photochem Photobiol B Biol. 2010;101(3):185–90.

    Article  CAS  Google Scholar 

  70. Allison RR, Sibata C, Gay H. PDT for cancers of the head and neck. Photodiagn Photodyn Ther. 2009;6(1):1–2.

    Article  Google Scholar 

  71. Biel MA. Photodynamic therapy of head and neck cancers. Methods Mol Biol (Clifton, NJ). 2010;635:281–93.

    Article  Google Scholar 

  72. Tan IB, Dolivet G, Ceruse P, Vander Poorten V, Roest G, Rauschning W. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck. 2010;32(12):1597–604.

    Article  PubMed  Google Scholar 

  73. Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 1996;78(7):1374–83.

    Article  CAS  PubMed  Google Scholar 

  74. Konopka K, Goslinski T. Photodynamic therapy in dentistry. J Dent Res. 2007;86(8):694–707.

    Article  CAS  PubMed  Google Scholar 

  75. D’Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck. 2004;26(3):232–40.

    Article  PubMed  Google Scholar 

  76. Jerjes W, Upile T, Akram S, Hopper C. The surgical palliation of advanced head and neck cancer using photodynamic therapy. Clin Oncol. 2010;22(9):785–91.

    Article  CAS  Google Scholar 

  77. Li LB, Luo RC, Liao WJ, Zhang MJ, Luo YL, Miao JX. Clinical study of photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma. Photodiagn Photodyn Ther. 2006;3(4):266–71.

    Article  CAS  Google Scholar 

  78. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212–9.

    Article  CAS  PubMed  Google Scholar 

  79. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med. 2007;39(5):386–93.

    Article  PubMed  Google Scholar 

  80. Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91(3):441–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Karakullukcu B, Nyst HJ, van Veen RL, Hoebers FJ, Hamming-Vrieze O, Witjes MJ, de Visscher SA, Burlage FR, Levendag PC, Sterenborg HJ, Tan IB. mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: development of a new method. Head Neck. 2012;34(11):1597–606.

    Article  PubMed  Google Scholar 

  82. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs. 1994;5(4):443–7.

    Article  CAS  PubMed  Google Scholar 

  83. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61(1):192–6.

    CAS  PubMed  Google Scholar 

  84. Reis Sousa C. Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol. 2004;16(1):21–5.

    Article  Google Scholar 

  85. Sur BW, Nguyen P, Sun CH, Tromberg BJ, Nelson EL. Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection. Photochem Photobiol. 2008;84(5):1257–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Saji H, Song W, Furumoto K, Kato H, Engleman EG. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res. 2006;12(8):2568–74.

    Article  CAS  PubMed  Google Scholar 

  87. Kim SG, Hong JW, Boo SH, Kim MG, Lee KD, Ahn JC, Hwang HJ, Shin JI, Lee SJ, Oh JK, Chung PS. Combination treatment of cetuximab and photodynamic therapy in SNU-1041 squamous cancer cell line. Oncol Rep. 2009;22(4):701–8.

    CAS  PubMed  Google Scholar 

  88. Ge R, Ahn JC, Shin JI, Bahk CW, He P, Chung PS. An in vitro and in vivo study of combination therapy with photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26). Photomed Laser Surg. 2011;29(3):155–60.

    Article  CAS  PubMed  Google Scholar 

  89. Compagnin C, Mognato M, Celotti L, Canti G, Palumbo G, Reddi E. Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy. Cell Prolif. 2010;43(3):262–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Datta SN, Allman R, Loh C, Mason M, Matthews PN. Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line. Br J Cancer. 1997;76(3):312–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Civantos FJ, Karakullukcu B, Biel M, Silver CE, Rinaldo A, Saba NF, Takes RP, Vander Poorten V, Ferlito A. A review of photodynamic therapy for neoplasms of the head and neck. Adv Ther. 2018;35(3):324–40.

    Article  CAS  PubMed  Google Scholar 

  92. Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med. 2006;38(5):522–31.

    Article  PubMed  Google Scholar 

  93. Carcenac M, Larroque C, Langlois R, van Lier JE, Artus JC, Pèlegrin A. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. Photochem Photobiol. 1999;70(6):930–6.

    CAS  PubMed  Google Scholar 

  94. Hamblin MR, Newman EL. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J Photochem Photobiol B Biol. 1994;26(2):147–57.

    Article  CAS  Google Scholar 

  95. Carcenac M, Dorvillius M, Garambois V, Glaussel F, Larroque C, Langlois R, Hynes NE, van Lier JE, Pèlegrin A. Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates. Br J Cancer. 2001;85(11):1787–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Yarmush ML, Thorpe WP, Strong L, Rakestraw SL, Toner M, Tompkins RG. Antibody targeted photolysis. Crit Rev Ther Drug Carrier Syst. 1993;10(3):197–252.

    CAS  PubMed  Google Scholar 

  97. Smith KA, Nelson PN, Warren P, Astley SJ, Murray PG, Greenman J. Demystified recombinant antibodies. J Clin Pathol. 2004;57(9):912–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Staneloudi C, Smith KA, Hudson R, Malatesti N, Savoie H, Boyle RW, Greenman J. Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer. Immunology. 2007;120(4):512–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008;60(15):1627–37.

    Article  CAS  PubMed  Google Scholar 

  100. Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Baba Y. Quantum dots as photosensitizers? Nat Biotechnol. 2004;22(11):1360–1.

    Article  CAS  PubMed  Google Scholar 

  101. Ma J, Chen JY, Idowu M, Nyokong T. Generation of singlet oxygen via the composites of water-soluble thiol-capped CdTe quantum dots-sulfonated aluminum phthalocyanines. J Phys Chem B. 2008;112(15):4465–9.

    Article  CAS  PubMed  Google Scholar 

  102. Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 2008;26(11):612–21.

    Article  CAS  PubMed  Google Scholar 

  103. Hamblin MR. Advances in photodynamic therapy: basic, translational, and clinical. Norwood: Artech House; 2008.

    Google Scholar 

  104. Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol. 2006;6(4):1159–66.

    Article  CAS  PubMed  Google Scholar 

  105. Zhang P, Steelant W, Kumar M, Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J Am Chem Soc. 2007;129(15):4526–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Wang C, Tao H, Cheng L, Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials. 2011;32(26):6145–54.

    Article  CAS  PubMed  Google Scholar 

  107. Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm. 2006;3(4):415–23.

    Article  CAS  PubMed  Google Scholar 

  108. Oo MK, Yang X, Du H, Wang H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine (Lond). 2008;3(6):777–86.

    Article  CAS  PubMed  Google Scholar 

  109. Chen B, Pogue BW, Hoopes PJ, Hasan T. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr. 2006;16(4):279–305.

    Article  PubMed  Google Scholar 

  110. Kurohane K, Tominaga A, Sato K, North JR, Namba Y, Oku N. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett. 2001;167(1):49–56.

    Article  CAS  PubMed  Google Scholar 

  111. Chen B, Crane C, He C, Gondek D, Agharkar P, Savellano MD, Hoopes PJ, Pogue BW. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int J Cancer. 2008;123(3):695–701.

    Article  CAS  PubMed  Google Scholar 

  112. Starkey JR, Rebane AK, Drobizhev MA, Meng F, Gong A, Elliott A, McInnerney K, Spangler CW. New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse. Clin Cancer Res. 2008;14(20):6564–73.

    Article  CAS  PubMed  Google Scholar 

  113. Collins HA, Khurana M, Moriyama EH, Mariampillai A, Dahlstedt E, Balaz M, Kuimova MK, Drobizhev M, Yang VXD, Phillips D, Rebane A, Wilson BC, Anderson HL. Blood-vessel closure using photosensitizers engineered for two-photon excitation. Nat Photonics. 2008;2(7):420–4.

    Article  CAS  Google Scholar 

  114. Brown S. Two photons are better than one. Nat Photonics. 2008;2(7):394–5.

    Article  CAS  Google Scholar 

  115. Karotki A, Khurana M, Lepock JR, Wilson BC. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy. Photochem Photobiol. 2006;82(2):443–52.

    Article  CAS  PubMed  Google Scholar 

  116. Korbelik M. Cancer vaccines generated by photodynamic therapy. Photochem Photobiol Sci: Off J Eur Photochem Assoc Eur Soc Photobiol. 2011;10(5):664–9.

    Article  CAS  Google Scholar 

  117. Holsinger FC, Ferris RL. Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trials. J Clin Oncol. 2015;33(29):3285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Quon H, Finlay J, Cengel K, Zhu T, O’Malley B Jr, Weinstein G. Transoral robotic photodynamic therapy for the oropharynx. Photodiagn Photodyn Ther. 2011;8(1):64–7.

    Article  Google Scholar 

  119. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA: Cancer J Clin. 2011;61(4):250–81.

    PubMed  Google Scholar 

  120. Selbo PK, Weyergang A, Høgset A, Norum OJ, Berstad MB, Vikdal M, Berg K. Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J Control Release: Off J Control Release Soc. 2010;148(1):2–12.

    Article  CAS  Google Scholar 

  121. Jerjes W, Theodossiou TA, Hirschberg H, Høgset A, Weyergang A, Selbo PK, Hamdoon Z, Hopper C, Berg K. Photochemical internalization for intracellular drug delivery: from basic mechanisms to clinical research. J Clin Med. 2020;9(2):528.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Berg K, Folini M, Prasmickaite L, Selbo PK, Bonsted A, Engesaeter B, Zaffaroni N, Weyergang A, Dietze A, Maelandsmo GM, Wagner E, Norum OJ, Høgset A. Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol. 2007;8(6):362–72.

    Article  CAS  PubMed  Google Scholar 

  123. Alzeibak R, Mishchenko TA, Shilyagina NY, Balalaeva IV, Vedunova MV, Krysko DV. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J Immunother Cancer. 2021;9(1):e001926.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Park S, Hwang J, Kwon Y, Cheon C. Antenna system applicable to microwave non-invasive hyperthermia lipolysis. Electron Lett. 2012;48(19):1179–81.

    Article  Google Scholar 

  125. Muehlmann LA, Joanitti GA, Silva JR, Longo JP, Azevedo RB. Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy. Braz J Med Biol. 2011;44(8):729–37.

    Article  CAS  Google Scholar 

  126. Davies AM, Weinberg U, Palti Y. Tumor treating fields: a new frontier in cancer therapy. Ann NY Acad Sci. 2013;1291:86–95.

    Article  PubMed  Google Scholar 

  127. Saczko J, Nowak M, Skolucka N, Kulbacka J, Kotulska M. The effects of the electro-photodynamic in vitro treatment on human lung adenocarcinoma cells. Bioelectrochemistry (Amsterdam, Netherlands). 2010;79(1):90–4.

    Article  CAS  PubMed  Google Scholar 

  128. Covello G, Siva K, Adami V, Denti MA. An electroporation protocol for efficient DNA transfection in PC12 cells. Cytotechnology. 2014;66(4):543–53.

    Article  CAS  PubMed  Google Scholar 

  129. Charoo NA, Rahman Z, Repka MA, Murthy SN. Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv. 2010;7(2):125–36.

    Article  CAS  PubMed  Google Scholar 

  130. Lambreva M, Glück B, Radeva M, Berg H. Electroporation of cell membranes supporting penetration of photodynamic active macromolecular chromophore dextrans. Bioelectrochemistry (Amsterdam, Netherlands). 2004;62(1):95–8.

    Article  CAS  PubMed  Google Scholar 

  131. Yang M, Yang T, Mao C. Enhancement of photodynamic cancer therapy by physical and chemical factors. Angew Chem Int Ed Engl. 2019;58(40):14066–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Pandita TK, Pandita S, Bhaumik SR. Molecular parameters of hyperthermia for radiosensitization. Crit Rev Eukaryot Gene Expr. 2009;19(3):235–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Manthe RL, Foy SP, Krishnamurthy N, Sharma B, Labhasetwar V. Tumor ablation and nanotechnology. Mol Pharm. 2010;7(6):1880–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Yao M, Ma L, Li L, Zhang J, Lim R, Chen W, Zhang Y. A new modality for cancer treatment-nanoparticle mediated microwave induced photodynamic therapy. J Biomed Nanotechnol. 2016;12(10):1835–51.

    Article  CAS  PubMed  Google Scholar 

  135. Vander Vorst A, Rosen A, Kotsuka Y. RF/microwave interaction with biological tissues. Hoboken: John Wiley & Sons; 2006.

    Google Scholar 

  136. Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Photodynamic therapy outcome for oral dysplasia. Lasers Surg Med. 2011;43(3):192–9.

    Article  PubMed  Google Scholar 

  137. Sieroń A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2003;32(6):330–6.

    Article  Google Scholar 

  138. Grant WE, Hopper C, Speight PM, Macrobert AJ, Bown SG. Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity. J Laryngol Otol. 1993;107(12):1140–5.

    Article  CAS  PubMed  Google Scholar 

  139. Yu CH, Chen HM, Hung HY, Cheng SJ, Tsai T, Chiang CP. Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion. Oral Oncol. 2008;44(6):595–600.

    Article  CAS  PubMed  Google Scholar 

  140. Lin HP, Chen HM, Yu CH, Yang H, Wang YP, Chiang CP. Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2010;39(8):624–30.

    Article  Google Scholar 

  141. Kübler A, Haase T, Rheinwald M, Barth T, Mühling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg. 1998;27(6):466–9.

    Article  PubMed  Google Scholar 

  142. Ikeda H, Tobita T, Ohba S, Uehara M, Asahina I. Treatment outcome of photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia. Photodiagn Photodyn Ther. 2013;10(3):229–35.

    Article  CAS  Google Scholar 

  143. Toratani S, Tani R, Kanda T, Koizumi K, Yoshioka Y, Okamoto T. Photodynamic therapy using photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up. Photodiagn Photodyn Ther. 2016;14:104–10.

    Article  CAS  Google Scholar 

  144. Jerjes W, Upile T, Hamdoon Z, Alexander Mosse C, Morcos M, Hopper CJLIS. Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma. Lasers Surg Med. 2011;43(6):463–9.

    Article  PubMed  Google Scholar 

  145. Wang X, Li N, Meng J, Wen NJAJOO. The use of topical ALA-photodynamic therapy combined with induction chemotherapy for locally advanced oral squamous cell carcinoma. Am J Otolaryngol. 2021;42(6):103112.

    Article  CAS  PubMed  Google Scholar 

  146. Ikeda H, Ohba S, Egashira K, Asahina IJP, Therapy P. The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma: a series of eight cases. Photodiag Photodyn Ther. 2018;21:176–80.

    Article  CAS  Google Scholar 

  147. Schweitzer VG, Somers ML. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx. Lasers Surg Med. 2010;42(1):1–8.

    Article  PubMed  Google Scholar 

  148. Karakullukcu B, Stoker SD, Wildeman AP, Copper MP, Wildeman MA, Tan IB. A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer. Eur Arch Oto-Rhino-Laryngol. 2013;270(3):1093–7.

    Article  Google Scholar 

  149. de Visscher SA, Melchers LJ, Dijkstra PU, Karakullukcu B, Tan IB, Hopper C, Roodenburg JL, Witjes MJ. mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment. Ann Surg Oncol. 2013;20(9):3076–82.

    Article  PubMed  Google Scholar 

  150. Vander Poorten V, Meulemans J, Nuyts S, Clement P, Hermans R, Hauben E, Delaere P. Postoperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongue. World J Surg Oncol. 2015;13(1):1–4.

    Article  Google Scholar 

  151. Jerjes UTW, Hamdoon Z, Abbas S, Akram S, Mosse CA, Morley S, Hopper C. Photodynamic therapy: the minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma. Lasers Surg Med. 2011;43(4):283–92.

    Article  PubMed  Google Scholar 

  152. van Doeveren TE, Karakullukçu MB, van Veen RL, Lopez-Yurda M, Schreuder WH, Tan IB. Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins. Laryngoscope. 2018;128(3):657–63.

    Article  PubMed  Google Scholar 

  153. Ahn PH, Quon H, O’Malley BW, Weinstein G, Chalian A, Malloy K, Atkins JH, Sollecito T, Greenberg M, McNulty S. Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors. Oral Oncol. 2016;55:37–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Rigual N, Shafirstein G, Cooper MT, Baumann H, Bellnier DA, Sunar U, Tracy EC, Rohrbach DJ, Wilding G, Tan W. Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res. 2013;19(23):6605–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Santos LL, Oliveira J, Monteiro E, Santos J, Sarmento CJ. Treatment of head and neck cancer with photodynamic therapy with redaporfin: a clinical case report. Case Rep Oncol. 2018;11(3):769–76.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Hosokawa S, Takebayashi S, Takahashi G, Okamura J, Mineta H. Photodynamic therapy in patients with head and neck squamous cell carcinoma. Lasers Surg Med. 2018;50(5):420–6.

    Article  PubMed  Google Scholar 

  157. Rigual NR, Shafirstein G, Frustino J, Seshadri M, Cooper M, Wilding G, Sullivan MA, Henderson B. Adjuvant intraoperative photodynamic therapy in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(7):706–11.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Caesar L, van Doeveren T, Tan I, Dilci A, van Veen R, Karakullukcu BJP, Therapy P. The use of photodynamic therapy as adjuvant therapy to surgery in recurrent malignant tumors of the paranasal sinuses. Photodiagn Photodyn Ther. 2015;12(3):414–21.

    Article  CAS  Google Scholar 

  159. Shafirstein G, Rigual NR, Arshad H, Cooper MT, Bellnier DA, Wilding G, Tan W, Merzianu M, Henderson BWJH. Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: phase Ib study. Head Neck. 2016;38(S1):E377–83.

    Article  PubMed  Google Scholar 

  160. von Beckerath MP, Reizenstein JA, Berner AL, Nordqvist KW, Landström FJ, Löfgren AL, Möller CG. Outcome of primary treatment of early laryngeal malignancies using photodynamic therapy. Acta Oto-Laryngol. 2014;134(8):852–8.

    Article  Google Scholar 

  161. Karakullukcu B, van Oudenaarde K, Copper MP, Klop W, van Veen R, Wildeman M, Bing Tan I. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Oto-Rhino-Laryngol. 2011;268(2):281–8.

    Article  Google Scholar 

  162. Lambert A, Nees L, Nuyts S, Clement P, Meulemans J, Delaere P, Vander Poorten V. Photodynamic therapy as an alternative therapeutic tool in functionally inoperable oral and oropharyngeal carcinoma: a single tertiary center retrospective cohort analysis. Front Oncol. 2021;11:626394.

    Article  PubMed  PubMed Central  Google Scholar 

  163. Durbec M, Cosmidis A, Fuchsmann C, Ramade A, Céruse P. Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx. Eur Arch Oto-Rhino-Laryngol. 2013;270(4):1433–9.

    Article  CAS  Google Scholar 

  164. Succo G, Rosso S, Fadda G, Fantini M, Crosetti EJP. Salvage photodynamic therapy for recurrent nasopharyngeal carcinoma. Photodiagn Photodyn Ther. 2014;11(2):63–70.

    Article  Google Scholar 

  165. Abbas S, Jerjes W, Upile T, Vaz F, Hopper CJP. The palliative role of PDT in recurrent advanced nasopharyngeal carcinoma: case series. Photodiagn Photodyn Ther. 2012;9(2):142–7.

    Article  Google Scholar 

  166. Stoker S, Indrasari S, Herdini C, Hariwiyanto B, Karakullukcu B, Dhamiyati W, Widayati K, Romdhoni A, Fles R, Haryana SJP, Therapy P. Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy. Photodiagn Photodyn Ther. 2015;12(3):519–25.

    Article  CAS  Google Scholar 

  167. Nyst HJ, Wildeman M, Indrasari S, Karakullukcu B, van Veen R, Adham M, Stewart F, Levendag P, Sterenborg H, Tan I. Temoporfin mediated photodynamic therapy in patients with local persistent and recurrent nasopharyngeal carcinoma after curative radiotherapy: a feasibility study. Photodiagn Photodyn Ther. 2012;9(3):274–81.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank their colleagues for their insightful comments.

Funding

There was no funding provided.

Author information

Authors and Affiliations

Authors

Contributions

Not applicable.

Corresponding authors

Correspondence to Mohsen Yazdanian or Hamid Tebyaniyan.

Ethics declarations

Competing interests

The authors claim to have no conflict of interest.

Ethical approval

There is no author-conducted research with humans or animals in this review article.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mosaddad, S.A., Namanloo, R.A., Aghili, S.S. et al. Photodynamic therapy in oral cancer: a review of clinical studies. Med Oncol 40, 91 (2023). https://doi.org/10.1007/s12032-023-01949-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-023-01949-3

Keywords

Navigation